EFFECT OF MAGNESIUM L-LACTATE SUPPLEMENT ON BLOOD PRESSURE AND CORRECTED QT INTERVAL IN A SAMPLE OF IRAQI WOMEN WITH METABOLIC SYNDROME.

What Was Tested

This randomized controlled trial looks at Vitamin D, K2, Magnesium and Zinc and Copper (Supplement) in the context of low blood pressure and orthostatic hypotension.

The aim: The current study was designed for evaluation the effect of oral magnesium l-lactate supplementation on blood pressure and corrected QT interval in a sample of Iraqi women.

Who Took Part

The abstract describes 58 patients taking part.

PubMed tags the participants as women only.

How the Study Was Run

The researchers set it up as a randomized and placebo-controlled study.

Because people in this Vitamin D, K2, Magnesium and Zinc study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.

The comparison arm used a placebo, so changes seen with Vitamin D, K2, Magnesium and Zinc could be set against what happens without it.

What Was Measured

PubMed files the paper under topics including Blood Pressure, Hypertension, Metabolic Syndrome, Magnesium, Blood Pressure Monitoring, Ambulatory, Lactic Acid and Iraq.

The authors tagged it with the keywords corrected QT and magnesium supplement.

What This Means in Plain Language

The paper is a randomized and placebo-controlled study of Vitamin D, K2, Magnesium and Zinc and Copper (Supplement) in 58 patients in people with low blood pressure and orthostatic hypotension.

Results are reported in around 5 sentences of the abstract; we leave them to the paper itself rather than summarise them.

The publication is from 2023 (Wiadomosci lekarskie (Warsaw, Poland : 1960)), a journal based in Poland.

More context: the Vitamin D, K2, Magnesium and Zinc compound page and the Copper (Supplement) compound page, Low blood pressure and orthostatic hypotension research.